Posted on 10/4/18
Verastem Is Now A Major Freshly Derisked Small Cap Oncology Opportunity
SummaryThe company got the FDA approval on Duvelisib (COPIKTRA) on 9/24, almost two weeks before deadline. The stock price tanked on a sell the news event.Next . . .
Posted on 8/15/18
Verastem: An Undervalued Rare Oncology Gem With Big Upcoming Catalysts
SummaryDuvelisib CLL/SLL (Chronic Lymphotic Leukemia/Small Lymphotic Leukemia) FDA priority review approval decision imminent.Duvelisib will be the only drug of its kind - a monotherapy PI3K dual . . .
Boston
